Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01858012 · ClinicalTrials.gov registry record
Insulin Resistance in HCV Infection
A clinical trial of Insulin Resistance, sponsored by University of California, San Francisco.
- Active
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT01858012 is a study of Insulin Resistance that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 250 participants, roughly in line with the 243-participant average among 120 other Insulin Resistance trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT01858012, a study of Insulin Resistance, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The study hypothesis is that the means by which HCV induces glucose intolerance is through impairment of B-cell function and compensatory hyperinsulinemia in predisposed Latinos with insulin resistance and that HCV eradication improves these abnormalities. It is also hypothesized that moderate alcohol consumption impact insulin sensitivity and secretion with Latinos with or without HCV infection.
Conditions Studied
Interventions
- BEHAVIORAL Moderate alcohol cessation
Study Locations (1)
California
- University of california San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2008-01-01 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01858012
The ClinicalTrials.gov registry entry for NCT01858012 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 243-participant average among 120 other Insulin Resistance trials with a reported enrollment target. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which Moderate alcohol cessation is the first listed.
NCT01858012 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01858012 about?
NCT01858012 is a clinical study titled "Insulin Resistance in HCV Infection". The study hypothesis is that the means by which HCV induces glucose intolerance is through impairment of B-cell function and compensatory hyperinsulinemia in predisposed Latinos with insulin resistance and that HCV eradication improves these abnormalities. It is also hypothesized that moderate alcoh...
What is the current status of trial NCT01858012?
This trial is currently active not recruiting. The enrollment target is 250 participants. The study started on 2008-01-01. Estimated completion is 2026-12-31.
What conditions does trial NCT01858012 study?
This clinical trial studies the following conditions: Insulin Resistance.
What interventions are being tested in trial NCT01858012?
The interventions under investigation include: Moderate alcohol cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01858012?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01858012 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Metabolic Effects of Angiotensin-(1-7)
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.